Company Filing History:
1 out of 495 
1 out of 258 Years Active: 2022
Title: The Innovative Contributions of Parvez Vora
Introduction
Parvez Vora is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of novel agents that target specific cellular markers. His work has implications for cancer treatment and diagnostics.
Latest Patents
Parvez Vora holds a patent for "CD133-binding agents and uses thereof." This patent focuses on innovative CD133-binding agents that can detect CD133-expressing cells and quantify levels of cellular CD133 expression. The applications of these agents extend to targeting CD133-expressing cells, decreasing levels of CD133 in these cells, and potentially treating or preventing cancer.
Career Highlights
Throughout his career, Parvez Vora has worked with prestigious institutions such as the University of Toronto and McMaster University. His research has contributed to advancements in understanding cellular markers and their roles in cancer biology.
Collaborations
Parvez has collaborated with notable colleagues, including Jason Moffat and Jarrett Adams. These partnerships have enhanced the scope and impact of his research endeavors.
Conclusion
Parvez Vora's innovative work in developing CD133-binding agents showcases his commitment to advancing cancer research and treatment. His contributions are significant in the ongoing fight against cancer, and his patent reflects the potential for future breakthroughs in this critical area of medicine.